Trial results on upadacitinib for the treatment of RA | Roy Fleischmann

Описание к видео Trial results on upadacitinib for the treatment of RA | Roy Fleischmann

Roy Fleischmann comments on the results of the SELECT-MONOTHERAPY and SELECT-NEXT trials, which provide further evidence for the benefits of upadacitinib in patients with RA.

View more on Medicine Matters rheumatology: https://bit.ly/fleischmann-select-trials

More from EULAR 2018: https://bit.ly/eular-2018-hub

Originally published on Medicine Matters rheumatology on June 26, 2018

Комментарии

Информация по комментариям в разработке